Panos C.
Co-founder & Director @Wecandev Consulting Group Inc
Signup · Get unlimited contacts
WORK HISTORY
Co-founder & Director @Wecandev Consulting Group Inc
Toronto, ON, CA
Co-lead a specialized CMC and Technical Operations advisory firm supporting advanced therapy and biologics companies across preclinical and IND-enabling stages. Define CMC architectures, control strategies, and governance frameworks that align scientific development with regulatory, clinical, and manufacturing objectives.• Develop stage-appropriate CMC strategies spanning process development, analytical frameworks, potency models, and risk-based control strategies aligned with ICH expectations.• Advise executive teams and investors on portfolio prioritization, development risk, budgeting, and resource allocation tied to value inflection milestones.• Lead technical due diligence, CDMO evaluation, contracting strategy, and tech transfer planning across multi-site externalized development models.• Design QbD-enabled development frameworks integrating DoE, multivariate analytics, and high-content data to strengthen process understanding and lifecycle scalability.• Build and manage cross-functional fractional teams delivering end-to-end CMC execution while maintaining regulatory readiness.
EDUCATION
University of Patras
Bachelor of Science (BSc), Biology/Biological Sciences, General
The University of Queensland
Doctor of Philosophy (Ph.D.), Biomedical Engineering
ABOUT PANOS C.
Executive CMC and Technical Operations leader with 15+ years of experience advancing complex therapeutic assets from early discovery through IND-enabling development and clinical readiness. Proven architect of stage-appropriate CMC strategies that de-risk novel modalities, align technical execution with capital deployment, and establish scalable development pathways for regulatory success.Experienced in building and leading multi-disciplinary, multi-site technical organizations, structuring externally networked CDMO models, and implementing QbD-driven control strategies that integrate Process & Analytical Development, Quality, and Regulatory functions. Demonstrated ability to translate early scientific innovation into robust, Fit-for-Purpose CMC frameworks that support value inflection, investor confidence, and sustainable product advancement.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.